421 related articles for article (PubMed ID: 22236282)
1. Δ⁹-tetrahydrocannabinol (Δ⁹-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease.
Carroll CB; Zeissler ML; Hanemann CO; Zajicek JP
Neuropathol Appl Neurobiol; 2012 Oct; 38(6):535-47. PubMed ID: 22236282
[TBL] [Abstract][Full Text] [Related]
2. Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis.
Zeissler ML; Eastwood J; McCorry K; Hanemann CO; Zajicek JP; Carroll CB
Oncotarget; 2016 Jul; 7(29):46603-46614. PubMed ID: 27366949
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of Delta(9)-tetrahydrocannabinol against N-methyl-d-aspartate-induced AF5 cell death.
Chen J; Lee CT; Errico S; Deng X; Cadet JL; Freed WJ
Brain Res Mol Brain Res; 2005 Apr; 134(2):215-25. PubMed ID: 15836919
[TBL] [Abstract][Full Text] [Related]
4. THC (Δ9-Tetrahydrocannabinol) Exerts Neuroprotective Effect in Glutamate-affected Murine Primary Mesencephalic Cultures Through Restoring Mitochondrial Membrane Potential and Anti-apoptosis Involving CB
Nguyen CH; Krewenka C; Radad K; Kranner B; Huber A; Duvigneau JC; Miller I; Moldzio R
Phytother Res; 2016 Dec; 30(12):2044-2052. PubMed ID: 27654887
[TBL] [Abstract][Full Text] [Related]
5. Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures.
Moldzio R; Pacher T; Krewenka C; Kranner B; Novak J; Duvigneau JC; Rausch WD
Phytomedicine; 2012 Jun; 19(8-9):819-24. PubMed ID: 22571976
[TBL] [Abstract][Full Text] [Related]
6. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.
Laprairie RB; Bagher AM; Kelly ME; Dupré DJ; Denovan-Wright EM
J Biol Chem; 2014 Sep; 289(36):24845-62. PubMed ID: 25037227
[TBL] [Abstract][Full Text] [Related]
7. Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson's disease.
García C; Palomo-Garo C; García-Arencibia M; Ramos J; Pertwee R; Fernández-Ruiz J
Br J Pharmacol; 2011 Aug; 163(7):1495-506. PubMed ID: 21323909
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective Effects of Cannabidiol but Not Δ
Landucci E; Mazzantini C; Lana D; Davolio PL; Giovannini MG; Pellegrini-Giampietro DE
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575932
[TBL] [Abstract][Full Text] [Related]
9. Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew.
Darmani NA; Janoyan JJ; Crim J; Ramirez J
Eur J Pharmacol; 2007 Jun; 563(1-3):187-96. PubMed ID: 17362921
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective Effect of JZL184 in MPP(+)-Treated SH-SY5Y Cells Through CB2 Receptors.
Aymerich MS; Rojo-Bustamante E; Molina C; Celorrio M; Sánchez-Arias JA; Franco R
Mol Neurobiol; 2016 May; 53(4):2312-9. PubMed ID: 25976369
[TBL] [Abstract][Full Text] [Related]
11. Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus.
Laaris N; Good CH; Lupica CR
Neuropharmacology; 2010; 59(1-2):121-7. PubMed ID: 20417220
[TBL] [Abstract][Full Text] [Related]
12. Biased Type 1 Cannabinoid Receptor Signaling Influences Neuronal Viability in a Cell Culture Model of Huntington Disease.
Laprairie RB; Bagher AM; Kelly ME; Denovan-Wright EM
Mol Pharmacol; 2016 Mar; 89(3):364-75. PubMed ID: 26700564
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effect of (-)Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite.
El-Remessy AB; Khalil IE; Matragoon S; Abou-Mohamed G; Tsai NJ; Roon P; Caldwell RB; Caldwell RW; Green K; Liou GI
Am J Pathol; 2003 Nov; 163(5):1997-2008. PubMed ID: 14578199
[TBL] [Abstract][Full Text] [Related]
14. Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.
Hampson AJ; Grimaldi M; Axelrod J; Wink D
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8268-73. PubMed ID: 9653176
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological manipulation of peroxisome proliferator-activated receptor γ (PPARγ) reveals a role for anti-oxidant protection in a model of Parkinson's disease.
Martin HL; Mounsey RB; Mustafa S; Sathe K; Teismann P
Exp Neurol; 2012 Jun; 235(2):528-38. PubMed ID: 22417924
[TBL] [Abstract][Full Text] [Related]
16. SIRT1 mediates salidroside-elicited protective effects against MPP
Wang CY; Sun ZN; Wang MX; Zhang C
Cell Biol Int; 2018 Jan; 42(1):84-94. PubMed ID: 28851138
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin Protects Dopaminergic Neurons Against MPP+-Induced Oxidative Stress and Regulates the Endogenous Anti-Oxidant System Through ERK.
Yan J; Qiao L; Wu J; Fan H; Sun J; Zhang Y
Cell Physiol Biochem; 2018; 51(4):1957-1968. PubMed ID: 30513525
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties.
García-Arencibia M; González S; de Lago E; Ramos JA; Mechoulam R; Fernández-Ruiz J
Brain Res; 2007 Feb; 1134(1):162-70. PubMed ID: 17196181
[TBL] [Abstract][Full Text] [Related]
19. Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.
García C; Gómez-Cañas M; Burgaz S; Palomares B; Gómez-Gálvez Y; Palomo-Garo C; Campo S; Ferrer-Hernández J; Pavicic C; Navarrete C; Luz Bellido M; García-Arencibia M; Ruth Pazos M; Muñoz E; Fernández-Ruiz J
J Neuroinflammation; 2018 Jan; 15(1):19. PubMed ID: 29338785
[TBL] [Abstract][Full Text] [Related]
20. miR-124-3p attenuates MPP
Geng L; Liu W; Chen Y
Exp Biol Med (Maywood); 2017 Dec; 242(18):1757-1764. PubMed ID: 28958159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
